Stimuvax Cancer Vaccine Phase III Study Begins
February 26th, 2007
Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).
At 2:46 pm on August 20th, 2009 Johnny said:
Anybody out there on the Stimuvax trial? I started last month, don’t know if I getting the drug or not, but I do know today my xrays are significantly improved? My wife thinks I’m getting the real thing… Anybody else having success?